What is the current annual cash from financing of EXAS?

As of today, EXAS annual cash from financing is $231.87M

What is 1-year change in EXAS annual cash from financing?

EXAS annual cash from financing is up +45.13% year-over-year

What is 3-year change in EXAS annual cash from financing?

EXAS annual cash from financing is up +2636.95% over the past 3 years

How far is EXAS annual cash from financing from its all-time high?

EXAS annual cash from financing is currently -87.66% below its historical high of $1.88B set on December 31, 2020

How does EXAS annual cash from financing rank versus sector peers?

EXAS annual cash from financing is higher than 91.26% of companies in Healthcare sector

When is EXAS next annual earnings release?

The next annual earnings release for EXAS is on February 25, 2026

What is the current quarterly cash from financing of EXAS?

As of today, EXAS quarterly cash from financing is -$1.53M

What is EXAS quarterly cash from financing most recent change?

EXAS quarterly cash from financing was up +66.06% on September 30, 2025

What is 1-year change in EXAS quarterly cash from financing?

EXAS quarterly cash from financing is down -577.88% year-over-year

How far is EXAS quarterly cash from financing from its all-time high?

EXAS quarterly cash from financing is currently -100.16% below its historical high of $979.48M set on March 31, 2020

How does EXAS quarterly cash from financing rank versus sector peers?

EXAS quarterly cash from financing is higher than 20.80% of companies in Healthcare sector

When is EXAS next earnings release?

The next earnings release for EXAS is on February 25, 2026

What is the current TTM cash from financing of EXAS?

As of today, EXAS TTM cash from financing is -$251.72M

What is EXAS TTM cash from financing most recent change?

EXAS TTM cash from financing was down -0.52% on September 30, 2025

What is 1-year change in EXAS TTM cash from financing?

EXAS TTM cash from financing is down -208.77% year-over-year

How far is EXAS TTM cash from financing from its all-time high?

EXAS TTM cash from financing is currently -113.39% below its historical high of $1.88B set on December 31, 2020

How does EXAS TTM cash from financing rank versus sector peers?

EXAS TTM cash from financing is higher than 8.72% of companies in Healthcare sector

When is EXAS next earnings release?

The next earnings release for EXAS is on February 25, 2026

EXAS Cash From Financing History & Chart Since 1997

Annual CFF

$231.87M$72.11M+45.13%

December 31, 2024

Summary

Current Value: As of today, EXAS annual cash from financing is $231.87M, up +45.13% on December 31, 2024
Historical Performance: EXAS annual cash from financing is up +2636.95% over the past 3 years, and down -8.42% over the past 5 years
All-Time High Comparison: EXAS annual cash from financing is currently -87.66% below its historical high of $1.88B set on December 31, 2020
3-Year Low Comparison: EXAS annual cash from financing is +203.16% above its 3-year low of $76.49M reached on an earlier date
Sector Comparison: EXAS annual cash from financing is higher than 91.26% of companies in Healthcare sector

Cash From Financing Chart

Add series to chart

Add series to chart1/6

Company, ETF, index, screener or watchlist

Series

Performance

EXAS Performance
Metric	Date	Value	1Y	3Y	5Y	15Y
Annual Cash From Financing	Dec 31, 24	$231.87M	+45.1%	+2636.9%	-8.4%	+613.6%
Quarterly Cash From Financing	Sep 30, 25	-$1.53M	-577.9%	-751.9%	-136.8%	-206.8%
TTM Cash From Financing	Sep 30, 25	-$251.72M	-208.8%	-564.5%	-125.0%	-1282.3%
Price	Jan 9, 26	$102.11	+80.2%	+73.6%	-22.1%	+1585.0%
Annual Cash From Operations	Dec 31, 24	$210.54M	+34.9%	+305.9%	+283.1%	+1765.6%
Annual Cash From Investing	Dec 31, 24	-$442.16M	-990.0%	+59.1%	-265.2%	-10000.0%
Annual Dividends Paid	Dec 31, 24	$0.00	0.0%	0.0%	0.0%	0.0%
Annual Total Debt	Dec 31, 24	$2.78B	+8.2%	+15.6%	+190.7%	+10000.0%
Shares Outstanding	Oct 31, 25	189.47M	+2.1%	+6.5%	+12.3%	–

Cash From Financing Highs

EXAS Annual Cash From Financing Highs Comparison
Period	High	Date	Current
3Y	$231.87M	Dec 31, 24	at high
5Y	$1.88B	N/A	-87.7%
All	$1.88B	Dec 31, 20	-87.7%

Cash From Financing Lows

EXAS Annual Cash From Financing Lows Comparison
Period	Low	Date	Current
3Y	$76.49M	N/A	+203.2%
5Y	$8.47M	Dec 31, 21	+2636.9%
All	$56.70K	Dec 31, 99	>+9999.0%

Cash From Financing History

Year	Value	Change
2024	$231.87M	+45.1%
2023	$159.77M	+108.9%
2022	$76.49M	+802.8%
2021	$8.47M	-99.5%
2020	$1.88B	+642.4%
2019	$253.18M	-72.9%
2018	$934.14M	+258.0%
2017	$260.96M	+74.5%
2016	$149.59M	-17.7%
2015	$181.77M	-25.5%
2014	$244.03M	+228.4%
2013	$74.30M	+23.8%
2012	$60.04M	+115.2%
2011	$27.90M	-67.2%

Year	Value	Change
2010	$85.19M	+162.2%
2009	$32.49M	>+9,900.0%
2008	$107.00K	-72.3%
2007	$386.00K	-18.4%
2006	$473.00K	+245.3%
2005	$137.00K	-99.7%
2004	$43.94M	+3,691.3%
2003	$1.16M	+88.5%
2002	$615.00K	-98.8%
2001	$50.78M	+58.7%
2000	$31.99M	>+9,900.0%
1999	$56.70K	-99.5%
1998	$10.56M	+6,077.6%
1997	$171.00K	-

FAQ

What is the current annual cash from financing of EXAS?
As of today, EXAS annual cash from financing is $231.87M
What is 1-year change in EXAS annual cash from financing?
EXAS annual cash from financing is up +45.13% year-over-year
What is 3-year change in EXAS annual cash from financing?
EXAS annual cash from financing is up +2636.95% over the past 3 years
How far is EXAS annual cash from financing from its all-time high?
EXAS annual cash from financing is currently -87.66% below its historical high of $1.88B set on December 31, 2020
How does EXAS annual cash from financing rank versus sector peers?
EXAS annual cash from financing is higher than 91.26% of companies in Healthcare sector
When is EXAS next annual earnings release?
The next annual earnings release for EXAS is on February 25, 2026

Quarterly CFF

-$1.53M$2.98M+66.06%

September 30, 2025

Summary

Current Value: As of today, EXAS quarterly cash from financing is -$1.53M, up +66.06% on September 30, 2025
Historical Performance: EXAS quarterly cash from financing is down -577.88% year-over-year, and down -751.91% over the past 3 years
All-Time High Comparison: EXAS quarterly cash from financing is currently -100.16% below its historical high of $979.48M set on March 31, 2020
3-Year Low Comparison: EXAS quarterly cash from financing is +99.40% above its 3-year low of -$256.17M reached on March 31, 2025
Sector Comparison: EXAS quarterly cash from financing is higher than 20.80% of companies in Healthcare sector

Performance

EXAS Performance
Metric	Date	Value	3M	1Y	3Y	5Y
Quarterly Cash From Financing	Sep 30, 25	-$1.53M	+66.1%	-577.9%	-751.9%	-136.8%
Annual Cash From Financing	Dec 31, 24	$231.87M	–	+45.1%	+2636.9%	-8.4%
TTM Cash From Financing	Sep 30, 25	-$251.72M	-0.5%	-208.8%	-564.5%	-125.0%
Price	Jan 9, 26	$102.11	+71.7%	+80.2%	+73.6%	-22.1%
Quarterly Cash From Operations	Sep 30, 25	$219.92M	+147.1%	+58.5%	+637.4%	+168.9%
Quarterly Cash From Investing	Sep 30, 25	-$86.45M	-138.4%	-5.8%	-233.0%	-613.8%
Quarterly Dividends Paid	Sep 30, 25	$0.00	0.0%	0.0%	0.0%	0.0%
Quarterly Total Debt	Sep 30, 25	$2.54B	-0.1%	-8.8%	+3.2%	+46.5%
Shares Outstanding	Oct 31, 25	189.47M	–	+2.1%	+6.5%	+12.3%

Quarterly Cash From Financing Highs

EXAS Quarterly Cash From Financing Highs Comparison
Period	High	Date	Current
1Y	$10.50M	N/A	-114.6%
3Y	$224.60M	Jun 30, 24	-100.7%
5Y	$879.86M	N/A	-100.2%
All	$979.48M	Mar 31, 20	-100.2%

Quarterly Cash From Financing Lows

EXAS Quarterly Cash From Financing Lows Comparison
Period	Low	Date	Current
1Y	-$256.17M	Mar 31, 25	+99.4%
3Y	-$256.17M	Mar 31, 25	+99.4%
5Y	-$256.17M	Mar 31, 25	+99.4%
All	-$256.17M	Mar 31, 25	+99.4%

Quarterly Cash From Financing History

Month	Value	Change
Sep 2025	-$1.53M	+66.1%
Jun 2025	-$4.51M	+98.2%
Mar 2025	-$256.17M	-2,540.0%
Dec 2024	$10.50M	+4,745.6%
Sep 2024	-$226.00K	-100.1%
Jun 2024	$224.60M	+7,581.8%
Mar 2024	-$3.00M	-129.9%
Dec 2023	$10.04M	>+9,900.0%
Sep 2023	$92.00K	-99.4%
Jun 2023	$16.04M	-88.0%
Mar 2023	$133.60M	+1,222.3%
Dec 2022	$10.10M	+4,199.1%
Sep 2022	$235.00K	-99.6%
Jun 2022	$63.41M	+2,218.5%
Mar 2022	$2.74M	+122.4%
Dec 2021	-$12.20M	>-9,900.0%
Sep 2021	$81.00K	-99.4%
Jun 2021	$13.34M	+84.2%
Mar 2021	$7.25M	-99.2%
Dec 2020	$879.86M	>+9,900.0%
Sep 2020	$4.16M	-74.2%
Jun 2020	$16.12M	-98.4%
Mar 2020	$979.48M	>+9,900.0%
Dec 2019	$6.62M	+575.9%
Sep 2019	$980.00K	-82.0%
Jun 2019	$5.45M	-97.7%
Mar 2019	$240.13M	+2,467.1%
Dec 2018	$9.35M	-51.0%
Sep 2018	$19.07M	-91.8%
Jun 2018	$233.28M	-65.3%
Mar 2018	$672.44M	>+9,900.0%
Dec 2017	$2.72M	+10.5%
Sep 2017	$2.46M	-99.0%
Jun 2017	$255.78M	>+9,900.0%
Mar 2017	$3,000.00	-99.9%
Dec 2016	$3.37M	-97.7%
Sep 2016	$144.71M	>+9,900.0%
Jun 2016	$1.27M	+413.0%
Mar 2016	$247.00K	-90.2%
Dec 2015	$2.51M	-98.6%
Sep 2015	$174.17M	+3,532.2%
Jun 2015	$4.80M	+1,525.4%
Mar 2015	$295.00K	-99.7%
Dec 2014	$105.87M	>+9,900.0%
Sep 2014	$136.00K	-99.9%
Jun 2014	$138.03M	>+9,900.0%
Mar 2014	$2,000.00	-95.5%
Dec 2013	$44.00K	-93.1%
Sep 2013	$636.00K	-99.1%
Jun 2013	$73.62M	>+9,900.0%

Month	Value	Change
Mar 2013	$8,000.00	-95.8%
Dec 2012	$191.00K	-99.7%
Sep 2012	$57.98M	>+9,900.0%
Jun 2012	$222.00K	-86.5%
Mar 2012	$1.64M	-94.0%
Dec 2011	$27.34M	+8,161.0%
Sep 2011	$331.00K	+56.9%
Jun 2011	$211.00K	+1,407.1%
Mar 2011	$14.00K	-100.0%
Dec 2010	$64.90M	+4,426.0%
Sep 2010	$1.43M	-91.9%
Jun 2010	$17.74M	+1,499.9%
Mar 2010	$1.11M	+10.3%
Dec 2009	$1.01M	+25.0%
Sep 2009	$804.00K	-90.0%
Jun 2009	$8.07M	-64.3%
Mar 2009	$22.61M	>+9,900.0%
Dec 2008	$1,000.00	-99.0%
Sep 2008	$100.00K	>+9,900.0%
Jun 2008	$0.00	-100.0%
Mar 2008	$6,000.00	-97.6%
Dec 2007	$254.00K	+117.1%
Sep 2007	$117.00K	>+9,900.0%
Jun 2007	$0.00	-100.0%
Mar 2007	$15.00K	-95.8%
Dec 2006	$354.00K	+637.5%
Sep 2006	$48.00K	+166.7%
Jun 2006	$18.00K	-66.0%
Mar 2006	$53.00K	+5,400.0%
Dec 2005	-$1,000.00	-101.5%
Sep 2005	$65.00K	+1,525.0%
Jun 2005	$4,000.00	-94.2%
Mar 2005	$69.00K	+1,625.0%
Dec 2004	$4,000.00	-96.2%
Sep 2004	$105.00K	-60.5%
Jun 2004	$266.00K	-99.4%
Mar 2004	$43.57M	>+9,900.0%
Dec 2003	$7,000.00	-99.2%
Sep 2003	$847.00K	+583.1%
Jun 2003	$124.00K	-31.5%
Mar 2003	$181.00K	+16.0%
Dec 2002	$156.00K	-18.8%
Sep 2002	$192.00K	+1,138.7%
Jun 2002	$15.50K	-93.8%
Mar 2002	$251.50K	+333.6%
Dec 2001	$58.00K	-58.6%
Sep 2001	$140.00K	+193.7%
Jun 2001	-$149.40K	-100.3%
Mar 2001	$50.73M	>+9,900.0%
Mar 2000	$1,600.00	-

FAQ

What is the current quarterly cash from financing of EXAS?
As of today, EXAS quarterly cash from financing is -$1.53M
What is EXAS quarterly cash from financing most recent change?
EXAS quarterly cash from financing was up +66.06% on September 30, 2025
What is 1-year change in EXAS quarterly cash from financing?
EXAS quarterly cash from financing is down -577.88% year-over-year
How far is EXAS quarterly cash from financing from its all-time high?
EXAS quarterly cash from financing is currently -100.16% below its historical high of $979.48M set on March 31, 2020
How does EXAS quarterly cash from financing rank versus sector peers?
EXAS quarterly cash from financing is higher than 20.80% of companies in Healthcare sector
When is EXAS next earnings release?
The next earnings release for EXAS is on February 25, 2026

TTM CFF

-$251.72M$1.31M-0.52%

September 30, 2025

Summary

Current Value: As of today, EXAS TTM cash from financing is -$251.72M, down -0.52% on September 30, 2025
Historical Performance: EXAS TTM cash from financing is down -208.77% year-over-year, and down -564.54% over the past 3 years
All-Time High Comparison: EXAS TTM cash from financing is currently -113.39% below its historical high of $1.88B set on December 31, 2020
3-Year Low Comparison: EXAS TTM cash from financing is at its 3-year low
Sector Comparison: EXAS TTM cash from financing is higher than 8.72% of companies in Healthcare sector

Performance

EXAS Performance
Metric	Date	Value	3M	1Y	3Y	5Y
TTM Cash From Financing	Sep 30, 25	-$251.72M	-0.5%	-208.8%	-564.5%	-125.0%
Annual Cash From Financing	Dec 31, 24	$231.87M	–	+45.1%	+2636.9%	-8.4%
Quarterly Cash From Financing	Sep 30, 25	-$1.53M	+66.1%	-577.9%	-751.9%	-136.8%
Price	Jan 9, 26	$102.11	+71.7%	+80.2%	+73.6%	-22.1%
TTM Cash From Operations	Sep 30, 25	$386.81M	+26.6%	+66.0%	+228.9%	+10000.0%
TTM Cash From Investing	Sep 30, 25	$62.13M	-7.1%	+113.3%	-70.5%	+105.0%
TTM Dividends Paid	Sep 30, 25	$0.00	0.0%	0.0%	0.0%	0.0%
Quarterly Total Debt	Sep 30, 25	$2.54B	-0.1%	-8.8%	+3.2%	+46.5%
Shares Outstanding	Oct 31, 25	189.47M	–	+2.1%	+6.5%	+12.3%

TTM Cash From Financing Highs

EXAS TTM Cash From Financing Highs Comparison
Period	High	Date	Current
1Y	$231.87M	N/A	-208.6%
3Y	$231.87M	Dec 31, 24	-208.6%
5Y	$1.88B	N/A	-113.4%
All	$1.88B	Dec 31, 20	-113.4%

TTM Cash From Financing Lows

EXAS TTM Cash From Financing Lows Comparison
Period	Low	Date	Current
1Y	-$251.72M	Sep 30, 25	at low
3Y	-$251.72M	Sep 30, 25	at low
5Y	-$251.72M	Sep 30, 25	at low
All	-$251.72M	Sep 30, 25	at low

TTM Cash From Financing History

Month	Value	Change
Sep 2025	-$251.72M	-0.5%
Jun 2025	-$250.41M	-1,075.9%
Mar 2025	-$21.30M	-109.2%
Dec 2024	$231.87M	+0.2%
Sep 2024	$231.41M	-0.1%
Jun 2024	$231.73M	+900.2%
Mar 2024	$23.17M	-85.5%
Dec 2023	$159.77M	-0.0%
Sep 2023	$159.83M	-0.1%
Jun 2023	$159.98M	-22.8%
Mar 2023	$207.35M	+171.1%
Dec 2022	$76.49M	+41.2%
Sep 2022	$54.19M	+0.3%
Jun 2022	$54.03M	+1,263.8%
Mar 2022	$3.96M	-53.2%
Dec 2021	$8.47M	-99.1%
Sep 2021	$900.53M	-0.5%
Jun 2021	$904.60M	-0.3%
Mar 2021	$907.39M	-51.7%
Dec 2020	$1.88B	+86.8%
Sep 2020	$1.01B	+0.3%
Jun 2020	$1.00B	+1.1%
Mar 2020	$992.54M	+292.0%
Dec 2019	$253.18M	-1.1%
Sep 2019	$255.91M	-6.6%
Jun 2019	$274.01M	-45.4%
Mar 2019	$501.83M	-46.3%
Dec 2018	$934.14M	+0.7%
Sep 2018	$927.51M	+1.8%
Jun 2018	$910.89M	-2.4%
Mar 2018	$933.39M	+257.7%
Dec 2017	$260.96M	-0.2%
Sep 2017	$261.60M	-35.2%
Jun 2017	$403.85M	+170.4%
Mar 2017	$149.34M	-0.2%
Dec 2016	$149.59M	+0.6%
Sep 2016	$148.73M	-16.5%
Jun 2016	$178.19M	-1.9%
Mar 2016	$181.72M	-0.0%
Dec 2015	$181.77M	-36.2%
Sep 2015	$285.12M	+156.7%
Jun 2015	$111.09M	-54.5%
Mar 2015	$244.32M	+0.1%
Dec 2014	$244.03M	+76.6%
Sep 2014	$138.21M	-0.4%
Jun 2014	$138.71M	+86.7%
Mar 2014	$74.30M	-0.0%
Dec 2013	$74.30M	-0.2%
Sep 2013	$74.45M	-43.5%
Jun 2013	$131.80M	+125.7%

Month	Value	Change
Mar 2013	$58.40M	-2.7%
Dec 2012	$60.04M	-31.1%
Sep 2012	$87.19M	+195.2%
Jun 2012	$29.54M	+0.0%
Mar 2012	$29.53M	+5.8%
Dec 2011	$27.90M	-57.4%
Sep 2011	$65.46M	-1.7%
Jun 2011	$66.56M	-20.8%
Mar 2011	$84.09M	-1.3%
Dec 2010	$85.19M	+300.1%
Sep 2010	$21.29M	+3.0%
Jun 2010	$20.66M	+88.0%
Mar 2010	$10.99M	-66.2%
Dec 2009	$32.49M	+3.2%
Sep 2009	$31.49M	+2.3%
Jun 2009	$30.79M	+35.5%
Mar 2009	$22.72M	>+9,900.0%
Dec 2008	$107.00K	-70.3%
Sep 2008	$360.00K	-4.5%
Jun 2008	$377.00K	0.0%
Mar 2008	$377.00K	-2.3%
Dec 2007	$386.00K	-20.6%
Sep 2007	$486.00K	+16.5%
Jun 2007	$417.00K	-4.1%
Mar 2007	$435.00K	-8.0%
Dec 2006	$473.00K	+300.8%
Sep 2006	$118.00K	-12.6%
Jun 2006	$135.00K	+11.6%
Mar 2006	$121.00K	-11.7%
Dec 2005	$137.00K	-3.5%
Sep 2005	$142.00K	-22.0%
Jun 2005	$182.00K	-59.0%
Mar 2005	$444.00K	-99.0%
Dec 2004	$43.94M	-0.0%
Sep 2004	$43.94M	-1.7%
Jun 2004	$44.69M	+0.3%
Mar 2004	$44.54M	+3,743.3%
Dec 2003	$1.16M	-11.4%
Sep 2003	$1.31M	+100.3%
Jun 2003	$653.00K	+19.9%
Mar 2003	$544.50K	-11.5%
Dec 2002	$615.00K	+19.0%
Sep 2002	$517.00K	+11.2%
Jun 2002	$465.00K	+54.9%
Mar 2002	$300.10K	-99.4%
Dec 2001	$50.78M	+0.1%
Sep 2001	$50.72M	+0.3%
Jun 2001	$50.58M	-0.3%
Mar 2001	$50.73M	>+9,900.0%
Mar 2000	$1,600.00	-

FAQ

What is the current TTM cash from financing of EXAS?
As of today, EXAS TTM cash from financing is -$251.72M
What is EXAS TTM cash from financing most recent change?
EXAS TTM cash from financing was down -0.52% on September 30, 2025
What is 1-year change in EXAS TTM cash from financing?
EXAS TTM cash from financing is down -208.77% year-over-year
How far is EXAS TTM cash from financing from its all-time high?
EXAS TTM cash from financing is currently -113.39% below its historical high of $1.88B set on December 31, 2020
How does EXAS TTM cash from financing rank versus sector peers?
EXAS TTM cash from financing is higher than 8.72% of companies in Healthcare sector
When is EXAS next earnings release?
The next earnings release for EXAS is on February 25, 2026

Cash From Financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

Data Sources & References

EXAS Official Website www.exactsciences.com
Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1124140/000112414025000091/0001124140-25-000091-index.htm
Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1124140/000112414025000020/0001124140-25-000020-index.htm
EXAS Profile on Yahoo Finance finance.yahoo.com/quote/EXAS
EXAS Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/exas